Using Blood Sugar AI to Tackle Obesity... Signos Raises 30.1 Billion Won in Investment

Signos raised $20 million in a new funding round to expand its AI-driven obesity and metabolic health platform.

The healthtech startup also signed a distribution deal with Dexcom to offer a subscription service through direct-to-consumer channels.

Signos uses AI and continuous glucose monitor data to predict blood sugar spikes before meals and deliver personalized health guidance.

The move comes as glucose-based weight-management tools gain traction alongside the rapid spread of GLP-1 therapies.